Krystal Biotech Inc (KRYS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Operating Expenses | 38,048 | 48,823 | 34,770 | 31,451 | 28,753 |
| Operating Income | -38,048 | -48,823 | -34,770 | -31,451 | -28,753 |
| Other Income | 4,838 | 3,526 | 2,718 | 1,601 | 645 |
| Pre-tax Income | -33,210 | -45,297 | -32,052 | -29,850 | -28,108 |
| Net Income Continuous | -33,210 | -45,297 | -32,052 | -29,850 | -28,108 |
| Net Income | $-33,210 | $-45,297 | $-32,052 | $-29,850 | $-28,108 |
| EPS Basic Total Ops | -1.25 | -1.76 | -1.23 | -1.17 | -1.10 |
| EPS Basic Continuous Ops | -1.25 | -1.76 | -1.24 | -1.17 | -1.10 |
| EPS Diluted Total Ops | -1.25 | -1.76 | -1.23 | -1.17 | -1.10 |
| EPS Diluted Continuous Ops | -1.25 | -1.76 | -1.24 | -1.17 | -1.10 |
| EBITDA(a) | $-36,570 | $-47,512 | $-34,351 | $-30,476 | $-27,777 |